Citadel Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.37M | Sell |
37,627
-218,922
| -85% | -$7.96M | ﹤0.01% | 3019 |
|
2025
Q1 | $9.29M | Sell |
256,549
-29,630
| -10% | -$1.07M | ﹤0.01% | 1300 |
|
2024
Q4 | $12M | Buy |
286,179
+238,226
| +497% | +$10M | ﹤0.01% | 1210 |
|
2024
Q3 | $2.66M | Sell |
47,953
-125,995
| -72% | -$7M | ﹤0.01% | 2257 |
|
2024
Q2 | $7.15M | Sell |
173,948
-119,357
| -41% | -$4.91M | ﹤0.01% | 1428 |
|
2024
Q1 | $13.7M | Buy |
293,305
+93,251
| +47% | +$4.35M | ﹤0.01% | 1099 |
|
2023
Q4 | $9.57M | Buy |
200,054
+198,653
| +14,179% | +$9.5M | ﹤0.01% | 1259 |
|
2023
Q3 | $49.9K | Sell |
1,401
-275,282
| -99% | -$9.81M | ﹤0.01% | 5081 |
|
2023
Q2 | $12.8M | Sell |
276,683
-281,133
| -50% | -$13M | ﹤0.01% | 1053 |
|
2023
Q1 | $22.4M | Buy |
557,816
+337,840
| +154% | +$13.5M | ﹤0.01% | 802 |
|
2022
Q4 | $10.2M | Buy |
219,976
+36,970
| +20% | +$1.71M | ﹤0.01% | 1299 |
|
2022
Q3 | $7.58M | Sell |
183,006
-834,297
| -82% | -$34.6M | ﹤0.01% | 1486 |
|
2022
Q2 | $60.7M | Sell |
1,017,303
-297,729
| -23% | -$17.8M | 0.02% | 297 |
|
2022
Q1 | $95.5M | Sell |
1,315,032
-128,415
| -9% | -$9.33M | 0.02% | 205 |
|
2021
Q4 | $121M | Sell |
1,443,447
-39,703
| -3% | -$3.34M | 0.02% | 157 |
|
2021
Q3 | $134M | Sell |
1,483,150
-373,329
| -20% | -$33.7M | 0.03% | 132 |
|
2021
Q2 | $177M | Buy |
1,856,479
+911,966
| +97% | +$87M | 0.04% | 81 |
|
2021
Q1 | $108M | Buy |
944,513
+438,003
| +86% | +$49.9M | 0.03% | 204 |
|
2020
Q4 | $70.1M | Buy |
506,510
+57,123
| +13% | +$7.91M | 0.02% | 314 |
|
2020
Q3 | $36.9M | Sell |
449,387
-207,833
| -32% | -$17.1M | 0.01% | 500 |
|
2020
Q2 | $51.4M | Sell |
657,220
-969,888
| -60% | -$75.9M | 0.02% | 366 |
|
2020
Q1 | $72.3M | Buy |
1,627,108
+128,466
| +9% | +$5.71M | 0.03% | 237 |
|
2019
Q4 | $64M | Buy |
1,498,642
+1,059,896
| +242% | +$45.3M | 0.03% | 338 |
|
2019
Q3 | $18.8M | Sell |
438,746
-45,320
| -9% | -$1.94M | 0.01% | 838 |
|
2019
Q2 | $30.7M | Sell |
484,066
-490,006
| -50% | -$31.1M | 0.01% | 588 |
|
2019
Q1 | $67.6M | Buy |
974,072
+963,599
| +9,201% | +$66.8M | 0.03% | 291 |
|
2018
Q4 | $456K | Sell |
10,473
-182,348
| -95% | -$7.94M | ﹤0.01% | 3320 |
|
2018
Q3 | $14.7M | Sell |
192,821
-274,751
| -59% | -$21M | 0.01% | 902 |
|
2018
Q2 | $35.9M | Sell |
467,572
-17,007
| -4% | -$1.31M | 0.02% | 497 |
|
2018
Q1 | $24.7M | Buy |
484,579
+190,219
| +65% | +$9.7M | 0.01% | 552 |
|
2017
Q4 | $13.7M | Buy |
294,360
+269,271
| +1,073% | +$12.5M | 0.01% | 813 |
|
2017
Q3 | $1.34M | Buy |
25,089
+20,746
| +478% | +$1.11M | ﹤0.01% | 2080 |
|
2017
Q2 | $270K | Sell |
4,343
-6,238
| -59% | -$388K | ﹤0.01% | 2978 |
|
2017
Q1 | $717K | Buy |
10,581
+7,074
| +202% | +$479K | ﹤0.01% | 2355 |
|
2016
Q4 | $247K | Sell |
3,507
-977
| -22% | -$68.8K | ﹤0.01% | 2926 |
|
2016
Q3 | $318K | Buy |
+4,484
| New | +$318K | ﹤0.01% | 2760 |
|
2016
Q2 | – | Sell |
-380,035
| Closed | -$24.1M | – | 3790 |
|
2016
Q1 | $24.1M | Buy |
380,035
+296,319
| +354% | +$18.8M | 0.03% | 410 |
|
2015
Q4 | $9.39M | Buy |
83,716
+26,574
| +47% | +$2.98M | 0.01% | 876 |
|
2015
Q3 | $5.5M | Sell |
57,142
-125,041
| -69% | -$12M | 0.01% | 1165 |
|
2015
Q2 | $18.7M | Sell |
182,183
-439,290
| -71% | -$45M | 0.02% | 726 |
|
2015
Q1 | $38.6M | Buy |
621,473
+248,618
| +67% | +$15.4M | 0.04% | 452 |
|
2014
Q4 | $16.4M | Buy |
372,855
+164,112
| +79% | +$7.2M | 0.02% | 736 |
|
2014
Q3 | $11.8M | Buy |
208,743
+2,168
| +1% | +$123K | 0.01% | 814 |
|
2014
Q2 | $9.27M | Buy |
206,575
+154,023
| +293% | +$6.91M | 0.01% | 850 |
|
2014
Q1 | $2.57M | Buy |
+52,552
| New | +$2.57M | ﹤0.01% | 1352 |
|